Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Miller-Rich Nancy Create: Alert

All | News | Filings
Date FiledTypeDescription
07/05/2023 4 Miller-Rich Nancy (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.
Txns: Granted 21,222 options to buy @ $8.39, valued at $178.1k
Granted 915 options to buy @ $8.39, valued at $7.7k
05/25/2023 4 Miller-Rich Nancy (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Granted 8,111 shares @ $0
Granted 12,547 options to buy @ $9.17, valued at $115.1k
05/25/2023 4 Miller-Rich Nancy (Director) has filed a Form 4 on 4D Molecular Therapeutics, Inc.
Txns: Granted 22,500 options to buy @ $17.98, valued at $404.6k
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/25/2022 4 Miller-Rich Nancy (Director) has filed a Form 4 on 4D Molecular Therapeutics, Inc.
Txns: Granted 22,500 options to buy @ $7.77, valued at $174.8k
11/09/2021 4 Miller-Rich Nancy (Director) has filed a Form 4 on Kadmon Holdings, Inc.
Txns: Disposed/sold 36,364 options to buy @ $4.17, valued at $151.6k
Disposed/sold 96,975 options to buy @ $3.58, valued at $347.2k
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2021 4 Miller-Rich Nancy (Director) has filed a Form 4 on 4D Molecular Therapeutics Inc.
Txns: Granted 22,500 options to buy @ $26.89, valued at $605k
05/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/10/2020 3 Miller-Rich Nancy (Director) has filed a Form 3 on 4D Molecular Therapeutics Inc.
08/13/2020 4 Miller-Rich Nancy (Director) has filed a Form 4 on Kadmon Holdings, Inc.
Txns: Granted 36,364 options to buy @ $4.17, valued at $151.6k
08/13/2020 3 Miller-Rich Nancy (Director) has filed a Form 3 on Kadmon Holdings, Inc.
06/11/2020 4 Miller-Rich Nancy (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.
Txns: Granted 26,503 options to buy @ $5.02, valued at $133k
06/01/2020 4 Miller-Rich Nancy (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Granted 1,595 shares @ $0
Granted 2,966 options to buy @ $72.74, valued at $215.7k
01/15/2020 4 Miller-Rich Nancy (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.
Txns: Granted 24,264 options to buy @ $6.15, valued at $149.2k
01/15/2020 3 Miller-Rich Nancy (Director) has filed a Form 3 on Aldeyra Therapeutics, Inc.
06/21/2019 4 Miller-Rich Nancy (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Granted 1,570 shares @ $0
Granted 2,174 options to buy @ $82.25, valued at $178.8k
06/22/2018 4 Miller-Rich Nancy (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Granted 4,373 shares @ $0
Granted 7,684 options to buy @ $85.12, valued at $654.1k
04/25/2018 3 Miller-Rich Nancy (Director) has filed a Form 3 on INTERCEPT PHARMACEUTICALS, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy